Risk of cancer in patients with inflammatory bowel diseases and keys for patient management

HIGHLIGHTS

• who: Viviana Laredo and colleagues from the Department of Gastroenterology, Lozano Blesa University Hospital, Zaragoza, Spain have published the paper: Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management, in the Journal: Cancers 2023, 15, 871. of /2023/
• what: __SECTION__ 7. Conclusions.
• how: Until tigate the risk of malignancy associated with IBD-therapy especially biologic therapy long-term safety results are obtained from this large cohort it is crucial to manage such .
• future: The risk of malignancies with tofacitinib exists but its magnitude and relationship with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.